Therapeutic Development of Interrelated Metabolic and Neurodegenerative Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|23|3608-3618

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.23, 2016-06, pp. : 3608-3618

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Efficacy of Selegiline in Neurodegenerative Disorders and Neurological Diseases

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1513-1529

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review

By  

Current Pharmaceutical Design, Vol. 20, Iss. 13, 2014-04 ,pp. : 2218-2230

Bentham Science Publishers

Access to resources Recommend Favorite

NAD Metabolism and Functions: A Common Therapeutic Target for Neoplastic, Metabolic and Neurodegenerative Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 23, 2013-12 ,pp. : 2918-2929

Bentham Science Publishers

Access to resources Recommend Favorite

Gut Microbiota as a Therapeutic Target for Metabolic Disorders

By  

Current Medicinal Chemistry, Vol. 25, Iss. 9, 2018-03 ,pp. : 984-1001

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Iron and Copper in the Aetiology of Neurodegenerative Disorders: Therapeutic Implications

By Perry G.   Sayre L.M.   Atwood C.S.   Castellani R.J.   Cash A.D.   Rottkamp C.A.   Smith M.A.  

CNS Drugs, Vol. 16, Iss. 5, 2002-01 ,pp. : 339-352

Adis International

Access to resources Recommend Favorite